These are the 10 worst U.S. states to live in for your mental health, according to a new study – Yahoo Finance

Overall well-being is influenced by your financial standing, relationships, work, sense of purpose, and safety, but where you live and your community’s health care system also play a vital role. In an analysis published last month, Universal Drugstore, an online pharmacy, ranked the best and worst states to live in for mental health, after evaluating dozens of data points including the prevalence of mental illness and the cost of care.
Montana came in number one for the best place to live for mental health, scoring 8.06 out of 10. The state had the lowest number by population of “mentally unhealthy adults” who cannot afford care, and residents took the second-least mental health sick days in 2022.
By contrast, Nevada is ranked the worst state for mental health with a score of 2.06 out of 10. The Silver State placed in the top 5 for several measurements including the highest number of mental health sick days taken and the most youth reporting depressive episodes. Nevada also has one of the lowest ratios of psychologists to residents across the nation.
Broken down further, South Dakota, ranked fourth as the best state for mental health, had the fewest reported mental health sick days (3), while West Virginia and Louisiana, ranked 34 and 44, reported the most (6). Adults in New Jersey, ranked 16th, have the lowest rates of mental illness diagnoses (16%), while adults residing in Utah, ranked 25th, have the highest rates of mental illness (27%). Oregon, in 50th place, ranked the second worst state for mental health with a score of 2.89 out of 10, tied with New Mexico, ranked 42nd, for the nation's highest percentage of youth experiencing depressive episodes (19%); the lowest is in Washington, D.C. (11%). D.C., ranked 13th, is also home to the highest proportion of psychologists compared to Alabama, Maine, Georgia, and Louisiana, which have seven per 100,000 residents.
Researchers used data from the U.S. Bureau of Labor Statistics, the Kaiser Family Foundation, Mental Health America, the U.S. Centers for Disease Control and Prevention, and the Substance Abuse and Mental Health Services Administration to compile the ranking. They compared each state’s ratio of psychologists to residents, the average number of mental health sick days taken, the prevalence of mental illness for adults and youth, the number of beds available and mental health facilities, and the cost of prescription drugs.
Nevada
Oregon
Oklahoma
Arizona
Washington
Texas
Alabama
Louisiana
Georgia
New Mexico
Montana
Vermont
Massachusetts
South Dakota
Rhode Island
Illinois
Wisconsin
North Dakota
Nebraska and Iowa (tied)
Arkansas
This story was originally featured on Fortune.com
The problem is when cortisol levels are consistently too high, it can put you at risk of a host of health conditions.
Bristol Myers Squibb (NYSE: BMY), Merck & Co Inc (NYSE: MRK), Pfizer Inc (NYSE: PFE) and Johnson & Johnson(NYSE: JNJ) are facing the so-called patent cliffs which imply revenue of tens of billions of dollars between now and and the end of this decade is at risk. The expiration of patents for one or more leading branded products for a company means opening the door to competitors to sell copycats of those drugs, often at a competitive price. But, as always, pharmaceutical companies do their best
Though early-stage results on Vincerx's (VINC) experimental drug did show signs of anti-tumor activity, the share price drops as some analysts stated that the results were below expectations.
Investors shelved their hopes for a pioneering cancer blood test after Illumina ‘s $8 billion acquisition of start-up Grail was scuttled by antitrust regulators last year. A decade from now, these blood tests could be used to flag the more than 60% of deadly cancers that currently lack any way to screen for them. At the annual meeting of the American Association for Cancer Research in San Diego, Exact Sciences reported on a 6,000-sample study of a multi-cancer test it plans to offer alongside single-cancer screening products such as its well-known Cologuard stool-based test for colon cancer.
Viking Therapeutics has garnered a lot of attention following a successful clinical trial for its obesity care drug. But another development-stage biotech may have a superior candidate.
Nurix (NRIX) rises on initial findings of clinical responses in the brain for its investigational targeted protein degrader, NX-5948, which is currently under development to treat B cell malignancies.
These rising drugmakers have serious arguments in their favor.
Moderna stock rallied after the company unveiled head-and-neck cancer treatment data. Is MRNA stock a buy or a sell right now?
Over the past 20 years, more than 400 million birds have either died from bird flu or from being culled to prevent its spread. Now, recent cases of bird flu in cats, cows and humans have raised the alarm of another serious pandemic. Bird flu is of particular concern to epidemiologists because of how lethal it is when humans get infected, with mortality rates around 50%. Don't Miss: Invest alongside exec’s from Uber, Facebook and Apple in this wellness app Transforming a $5.6 TRILLION dollar indu
The company responsible for a global recall of sleep apnea machines will be barred from resuming production at U.S. facilities until it meets a number of safety requirements, under a long-awaited settlement announced Tuesday by federal officials. Philips will be required to overhaul its manufacturing and quality control systems and hire independent experts to vet the changes, according to a court order announced by the U.S. Department of Justice. The action is a major step toward resolving one of the biggest medical device recalls in history, which has dragged on for nearly three years.
On Monday, Vincerx Pharma Inc (NASDAQ:VINC) presented preliminary Phase 1 data for VIP236 and updates on pipeline progress at the American Association for Cancer Research Annual Meeting 2024. VNC-236-101 is a Phase 1 dose-escalation study with monotherapy VIP236 for metastatic tumor patients who have exhausted all standard therapy options. Fifteen patients have been dosed to date on the once-every-three-weeks (Q3W) schedule: The Q3W schedule is well tolerated with no dose-limiting toxicity (DLT)
Vivos Therapeutics CEO Kirk Huntsman joined Steve Darling from Proactive shared significant news regarding the regulatory approval for Medicare reimbursement of their oral medical devices designed …
The watchdog group said the popular meal kit marketed toward kids should not be allowed on school menus and urged the USDA to remove it as an option.
Ergonomic keyboards reposition your hands and arms which could help you feel less strain as you work. We tried different types and this is what we think.
The FDA bestows an Orphan Drug designation to Lisata's (LSTA) lead investigational product candidate, LSTA1, for the treatment of osteosarcoma. Stock rises.
Pfizer said on Tuesday its respiratory syncytial virus (RSV) vaccine Abrysvo was well tolerated and generated an immune response in higher risk adults under the age of 60 similar to that in older adults, for whom the shot is already approved. Pfizer said it plans to submit its findings from the trial to seek expanded approval of the vaccine in adults ages 18 to 59, but did not give a time frame for when it expects the data to be considered by regulators. "This represents a real opportunity for an expansion to an age population in a risk population that wouldn't normally see the availability of this vaccine so soon," Dr. Iona Munjal, executive director of clinical vaccine R&D at Pfizer, said in an interview.
A deadline for the White House to review a proposal to ban the extra-addictive cigarettes expired last month with no action
Drug company Pfizer is seeking to expand the approval of its respiratory syncytial virus vaccine to include adults over the age of 18.
“You can't just eat creatine and hope that you wake up bigger and stronger.”
Planet Fitness Inc. (NYSE:PLNT) Founder and CEO Mike Grondahl detailed a history of rampant abuse at the company and alleged it misrepresented its financials during a recent interview with controversial right-wing X user Libs of TikTok. This comes after weeks of calls for boycotts of the brand after the company canceled the membership of a Planet Fitness gym goer after speaking out about a biological male in the women's locker room. Planet Fitness's policy allows gym members to use the locker ro

source

Leave a Comment

Your email address will not be published. Required fields are marked *